Four Lenoir County students selected for N.C. Governor's School
LENOIR COUNTY, N.C. (WNCT) — Four Lenoir County Public Schools students were selected to attend the North Carolina Governor's School for the summer of 2025.
Established in 1963, NC Governor's School is a prestigious, esteemed program. It is a publicly funded residential summer program that enrolls around 800 students each year and is split between two campuses: Governor's School West (GSW) at Greensboro College and Governor's School East (GSE) at Meredith College in Raleigh. It serves students from public, private, and home schools, primarily rising seniors, with some rising juniors in certain art areas. Students are selected based on a comprehensive evaluation process that includes grades, test scores, application essays, and auditions for arts students. Every student is accepted into a primary course of study, Area I, that includes disciplines such as English, Spanish, mathematics, natural science, social science, art, choral music, dance, drama, and instrumental music.
The LCPS students selected for the Governor's School Class of 2025 are:● Alicia Gonzalez-Gutierrez, Early College High School – Mathematics (first photo)● Jenna Van, Early College High School – Natural Science (second photo)● Braden Barnett, South Lenoir High School – Natural Science (third photo)● Campbell Price, South Lenoir High School – Social Science (third photo)
Photos curtesy of Lenoir County Public Schools
'We are incredibly proud of these students for earning a place in such a prestigious program,'LCPS Superintendent Brent Williams said. 'Their selection is a testament to their dedication,creativity, and academic excellence, as well as the unwavering support from our educators.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
How our 3 largest local school districts did on the 2025 Spring STAAR tests
AUSTIN (KXAN) — Central Texas' three most populous districts scored better on the Spring 2025 STAAR test's algebra and biology sections compared to the Spring 2024 tests, but worse on the English sections, according to data released Tuesday by the Texas Education Agency (TEA). Texas Education Agency releases Spring 2025 STAAR test results Due to the volume of data, KXAN looked at the STAAR EOC test group summaries for our three largest districts: Austin ISD, Leander ISD and Round Rock ISD. Compared to last year's results, AISD students did worse on the English II test but were roughly in line with last year's English I results. LISD and RRISD did better than AISD on those sections; however, both experienced slight drops in their English I and II scores compared to 2024 AISD students also did better on the U.S. History portion. LISD students did worse than last year, but still performed better than AISD on the section. RRISD students scored about the same on history as they did in 2024. Texas as a whole did better on biology than it did in 2024. AISD saw that improvement reflected in its scores. LISD and RRISD's scores in biology did not change significantly. The LISD-RRISD similarities didn't carry over to algebra — AISD and LISD both improved on the section but RRISD did not. If you're interested in another district, the TEA has results for all districts available online. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
6 hours ago
- Yahoo
Penn State environmental program receives state award
PENNSYLVANIA (WTAJ) — A Penn State program is one of 19 projects that have been granted the 2025 Governor's Awards for Environmental Excellence. The projects were evaluated on their degree of environmental protection, innovation, partnership, economic impact, consideration of climate change, sustainability, and environmental justice, as well as outcomes achieved. SCASD to pay $150k to settle discrimination lawsuit Penn State's Center for Science and the Schools AG Seed-Lings program was one of the awardees. The program is a K-5 educational program funded by a USDA NIFA K-14 grant. It works to teach students about pollination, pollinators and their impact on food security. The program's curriculum consists of 19 STEELS-aligned lessons provided in both English and Spanish. Last year, the program was implemented in 42 school districts and reached over 1,700 students. 'The Environmental Excellence honorees embody the innovative thinking needed to protect our environment and shape a more sustainable future here in Pennsylvania,' Department of Environmental Protection Acting Secretary Jessica Shirley said. 'Together, we will spur the next generation of environmental stewards. These projects showcase our ability to work collaboratively to preserve and protect Pennsylvania's natural resources.' You can read about the other 18 projects and what they're doing for their community on the Department of Environmental Protection website. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
11 hours ago
- Yahoo
SpliceBio lands $135M for a new kind of eye gene therapy
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. SpliceBio, a Spanish biotechnology company working on next-generation gene therapies, said Wednesday it raised $135 million in a Series B round to advance its lead program in Stargardt disease into further clinical testing. The startup is built around a technology that's meant to overcome a key limitation of current gene therapies. Scores of gene therapy developers use adeno-associated viruses, or AAVs, to deliver genetic cargo into the body. But because of their small size, AAVs can't carry larger corrective genes, leaving many diseases out of reach or forcing companies to come up with creative solutions. One example is in Duchenne muscular dystrophy. Because of the large size of the gene coding for the muscle-protecting protein dystrophin Duchenne patients lack, several companies, like Sarepta Therapeutics, have developed gene therapies that make a shortened form. The approach comes with drawbacks, however, as a truncated version of the protein might not work as well as the original. SpliceBio has a different workaround. The company is using two separate AAVs to send pieces of a large gene into cells. Once inside, specially engineered splicing molecules help reassemble their cargo into full-length proteins. Stargardt disease, for example, is caused by mutations to the ABCA4 gene, which is too large to stuff into an AAV. SpliceBio says its method can help the body produce a functional version of the protein that gene produces. Its lead program, SB-007, is in a Phase 1/2 trial. SpliceBio isn't the only biotech pursuing this type of approach to treat Stargardt, an inherited eye condition that causes progressive vision loss. Another European company, AAVantgarde, has a similar type of program in early-stage testing. SpliceBio's technology is based on research conducted at Princeton University, where co-founder and CEO Miquel Vila-Perelló was studying protein design and engineering. Launched in 2014 under the name ProteoDesign, the biotech is also working on additional programs in ophthalmology, neurology and other undisclosed therapeutic areas. Its Series B round was co-led by EQT Life Sciences and Sanofi Ventures, and involved seven other backers including Roche Venture Fund, New Enterprise Associates and Novartis Venture Fund. "The support from such high-quality investors underscores the strength of our programs and our unique protein splicing platform and its potential to unlock gene therapies for diseases that remain untreatable today,' Vila-Perelló said in a statement. The company raised €50 million in a Series A round in 2022. Gene and cell therapy startups backed by the roughly two dozen investment firms BioPharma Dive tracks have secured a little over $1.1 billion in venture dollars so far in 2025. Half of those fundings have come in the form of 'megarounds' exceeding $100 million apiece, continuing an ongoing trend. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
